Difference between revisions of "Lestaurtinib (CEP-701)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Kinase inhibitors" to "") |
m |
||
| Line 1: | Line 1: | ||
In clinical trials. | In clinical trials. | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Code name:''' CEP-701 | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| Line 9: | Line 12: | ||
[[Category:Investigational drugs]] | [[Category:Investigational drugs]] | ||
| + | [[Category:Stub]] | ||
Revision as of 13:56, 16 December 2020
In clinical trials.
Also known as
- Code name: CEP-701